European Biotech Investors Cap Off Record Year in Fundraising
The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health…
The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health…
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a…
The UK-based venture capital investment firm Medicxi has closed its third fund, totaling €400M, to…
Breakpoint Therapeutics, a spinoff from the German biotech Evotec, has raised €30M to develop drugs…
Christmas might have passed, but we have more videos for you to watch on a…
Kevin Johnson, Partner at Medicxi, joined us last week for our Meetup in London. He…
Kevin Johnson told me the story and lessons of his career, from CTO of Cambridge…
We all know conferences are important. To be on the same page, let’s brainstorm the…
The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and…
UPDATE (07/03/2017): ObsEva has announced the start of its Phase III trials for nolasiban, an oral…
SuperX has raised €10.3M ($11M) in Series A from Medicxi and J&J Innovation to develop…
Personalized medicine has been a popular topic in the last few years, but when will…